The Latest Headlines at American Banking and Market News
Hibbett (NASDAQ:HIBB) Sees Unusually-High Trading Volume Following Analyst Upgrade
Hibbett, Inc. (NASDAQ:HIBB – Get Free Report) saw an uptick in trading volume on Wednesday after B. Riley raised their price target on the stock from $70.00 to $87.50. B. Riley currently has a neutral rating on the stock. 365,591... More of this article »
Independent Bank Group (NASDAQ:IBTX) Shares Gap Down on Analyst Downgrade
Independent Bank Group, Inc. (NASDAQ:IBTX – Get Free Report) gapped down before the market opened on Wednesday after Hovde Group lowered their price target on the stock from $53.00 to $46.00. The stock had previously closed at... More of this article »
Medpace (NASDAQ:MEDP) Sets New 12-Month High Following Analyst Upgrade
Shares of Medpace Holdings, Inc. (NASDAQ:MEDP – Get Free Report) reached a new 52-week high during trading on Wednesday after Guggenheim raised their price target on the stock from $453.00 to $464.00. Guggenheim currently has... More of this article »
Research Analysts Set Expectations for Squarespace, Inc.’s FY2028 Earnings (NYSE:SQSP)
Squarespace, Inc. (NYSE:SQSP – Free Report) – Equities researchers at B. Riley upped their FY2028 earnings estimates for shares of Squarespace in a research note issued on Tuesday, April 23rd. B. Riley analyst N. Khan... More of this article »
Atb Cap Markets Comments on Yangarra Resources Ltd.’s FY2028 Earnings (TSE:YGR)
Yangarra Resources Ltd. (TSE:YGR – Free Report) – Investment analysts at Atb Cap Markets decreased their FY2028 earnings per share (EPS) estimates for Yangarra Resources in a report issued on Monday, April 22nd. Atb... More of this article »
FY2026 EPS Estimates for Halozyme Therapeutics, Inc. (NASDAQ:HALO) Raised by Analyst
Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) – Equities researchers at Zacks Research raised their FY2026 earnings per share (EPS) estimates for Halozyme Therapeutics in a research note issued to investors... More of this article »
Q3 2026 EPS Estimates for Cimpress plc (NASDAQ:CMPR) Raised by Zacks Research
Cimpress plc (NASDAQ:CMPR – Free Report) – Zacks Research lifted their Q3 2026 earnings per share (EPS) estimates for shares of Cimpress in a note issued to investors on Tuesday, April 23rd. Zacks Research analyst R.... More of this article »
Zacks Research Research Analysts Cut Earnings Estimates for Knight-Swift Transportation Holdings Inc. (NYSE:KNX)
Knight-Swift Transportation Holdings Inc. (NYSE:KNX – Free Report) – Zacks Research decreased their FY2026 earnings estimates for Knight-Swift Transportation in a report issued on Tuesday, April 23rd. Zacks Research... More of this article »
Q1 2026 EPS Estimates for Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Lowered by Analyst
Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) – Investment analysts at Zacks Research dropped their Q1 2026 earnings per share (EPS) estimates for Sarepta Therapeutics in a research report issued to clients... More of this article »
Apogee Enterprises, Inc. (NASDAQ:APOG) to Post FY2025 Earnings of $4.54 Per Share, DA Davidson Forecasts
Apogee Enterprises, Inc. (NASDAQ:APOG – Free Report) – Equities research analysts at DA Davidson lifted their FY2025 earnings per share (EPS) estimates for shares of Apogee Enterprises in a research report issued on... More of this article »
National Bank Financial Weighs in on Altius Renewable Royalties Corp.’s FY2026 Earnings (TSE:ARR)
Altius Renewable Royalties Corp. (TSE:ARR – Free Report) – Analysts at National Bank Financial issued their FY2026 EPS estimates for Altius Renewable Royalties in a report released on Monday, April 22nd. National Bank... More of this article »
Research Analysts Issue Forecasts for Lithium Americas Corp.’s FY2026 Earnings (NYSE:LAC)
Lithium Americas Corp. (NYSE:LAC – Free Report) – Stock analysts at Scotiabank dropped their FY2026 earnings per share estimates for shares of Lithium Americas in a research report issued to clients and investors on... More of this article »
Zacks Research Research Analysts Lift Earnings Estimates for Apellis Pharmaceuticals, Inc. (NASDAQ:APLS)
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) – Stock analysts at Zacks Research boosted their Q2 2025 earnings estimates for Apellis Pharmaceuticals in a research report issued on Tuesday, April 23rd. Zacks... More of this article »